75 posts categorized in

Research

  

On the CUSP: February 2023

March 3, 2023 by | Pharmacy

Grants Dr. Sherry Wang has been declared the Principal Investigator for her study titled: “A real-world study assessing utilization of buprenorphine treatments”. The New Investigator Award is provided by the American Association of Colleges of Pharmacy. Dr. Ajay Sharma has received a $1.7 million dollar grant from the National Eye Institute for his study on

Dr. Enrique Seoane-Vazquez Contributes to JAMA Internal Medicine Journal, Finds US Pays High Cost for Drugs Not Recommended in Other Countries

February 14, 2023 by | Pharmacy

Dr. Enrique Seoane-Vazquez has published a new study in JAMA Internal Medicine that examined why some new drugs approved in the US have not been approved or recommended for reimbursement in other countries, and how costly these drugs are, alongside Dr. Catherine Pham, former Chapman University School of Pharmacy/Kaiser Permanente Pharmaceutical Economics and Policy Fellow,

National Eye Institute Awards Dr. Ajay Sharma for Ocular Research

February 14, 2023 by | Pharmacy

Dr. Ajay Sharma has been awarded a $1.71 million grant from the National Eye Institute (NEI) for a five-year research project to investigate the pathology of ocular Graft versus Host Disease (oGVHD). Dr. Sharma’s research will investigate the role of a specific type of immune cells called “macrophages” in oGVHD. About half of the oGVHD patients

On the CUSP: January 2023

February 3, 2023 by | Pharmacy

Awards and Recognitions The Chapman/SCAN/Providence PGY1 Managed Care Residency was selected by the Greater Irvine Chamber for the Healthcare in Collaboration Award. An equal partnership between Chapman, SCAN Health Plan, and Providence Medical Foundation, the award was received by Dr. Jelena Lewis and accompanied by other Chapman representatives, including Dean Dr. Ren Ostrom, Associate Deans

On the CUSP: December 2022

January 6, 2023 by | Pharmacy

The last month of 2022 brought on significant accomplishments to an already remarkable year for the Chapman University School of Pharmacy. In December, both students and faculty represented at the largest gathering of pharmacy professionals in the world, Dr. Amy Kang was named an ACCP Junior Investigator, and CUSP researchers authored articles on diverse topics

Dr. Amy Kang Named ACCP Futures Grant Awardee

December 16, 2022 by | Pharmacy

The American College of Clinical Pharmacy (ACCP) has named Dr. Amy Kang, an assistant professor at Chapman Pharmacy, a recipient of the Futures Grant at the Junior Investigator level. This award titles Dr. Kang as one of the clinical pharmacy’s most promising early-career contributors to future clinical research. The grant will support her in continuing to

ASHP 2022: What happened in Vegas isn’t staying in Vegas

December 13, 2022 by | Pharmacy

Every year, pharmacy schools from across the nation gather at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition for educational programming, national posters, and presentations, and to be a part of one of the largest pharmaceutical conferences in the world. Chapman Pharmacy faculty and students triumphed (yet again) in all aspects

R03 Grant Recipient Dr. Sherif Elshahawi

December 7, 2022 by | Pharmacy

Dr. Sherif Elshahawi has been declared a recipient of the R03 grant from NIH (National Institutes of Health) to continue his work inventing antibiotics that inhibit resistant bacteria to “last resort” antibiotics. Dr. Elshahawi received $138,000 from the NIAID (Award # 1R03AI168826-01A1) for his proposal titled “Mechanisms and In Vivo Activity of a Next Generation

On the CUSP: November 2022

December 1, 2022 by | Pharmacy

That’s a wrap on November 2022! Chapman Pharmacy had an exceptionally busy month, including receiving the NIH R03 Grant and extensive participation in the California Society of Health-System Pharmacists (CSHP) 2022 Seminar. Grants Dr. Sherif Elshahawi became the recipient of the NIH R03 Grant (Award # 1R03AI168826-01A1) with a total amount of $138,000 from the

Log In
Open Main Menu